Abiopharma

🔍 Hoerter Steven L. (Executive)

Company: MBX Biosciences, Inc. (MBX)

Report Date: 2026-06-04

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-04 | Code: H | shares_owned_after: 11,938.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-04 | Code: H | nature_of_ownership: Trust | shares_owned_after: 20,000.00 | Footnotes: F1
• Acquired 12,500 shares of Stock option (right to buy) at $30.91 per share (Derivative)
  Date: 2026-06-04 | Code: A | Expires: 2036-06-04 | equity_swap_involved: false | shares_owned_after: 12,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
• F2: The grant will vest in full on the earlier of the one-year anniversary of the grant date or on the date of our next annual meeting of stockholders, subject to the non-employee director's continued services to the Company.